Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported a...
Main Authors: | Panpan Meng, Yi-Fan Zhang, Wangli Zhang, Xin Chen, Tong Xu, Sheng Hu, Xinjun Liang, Mingqian Feng, Xiaoqing Yang, Mitchell Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-79524-3 |
Similar Items
-
Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
by: Bryan D. Fleming, et al.
Published: (2016-09-01) -
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
by: Bryan D. Fleming, et al.
Published: (2020-06-01) -
The quest for ligands and binding partners of atypical cadherin FAT1
by: Khushboo Irshad, et al.
Published: (2021-07-01) -
A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors
by: Weili Mao, et al.
Published: (2022-08-01) -
Postnatal expression profiles of atypical cadherin FAT1 suggest its role in autism
by: Jeannine A. Frei, et al.
Published: (2021-06-01)